When To Apply

Study approval must be obtained PRIOR to enrolling users at the study site. Each site must have an approval from the reviewing IRB for that site prior to the beginning the study. For significant risk-device studies, in addition to IRB approvals, the sponsor must also have an approved IDE from FDA prior to beginning the study at any site. The review of applications to FDA and to the IRBs are independent and, therefore, may be submitted simultaneously.